Skip to content

Comparison of the clinical efficacy of polyglutamic acid repair solution and minoxidil introduction in the treatment of androgenetic alopecia

Comparison of the clinical efficacy of polyglutamic acid repair solution and minoxidil introduction in the treatment of androgenetic alopecia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107052
Enrollment
Unknown
Registered
2025-08-01
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic alopecia

Interventions

Experimental group:Polyglutamate solution induction versus minoxidil induction (1 time in 2 weeks of 6 sessions)

Sponsors

The Second Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for androgenetic alopecia (2019 edition of the Chinese Guidelines for the Diagnosis and Treatment of Androgenetic Alopecia); 2. Male, aged 18 to 55 years; 3. Use polyglutamic acid repair solution or minoxidil introductory treatment; 4. Voluntarily agree to participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Hair follicles have atrophied under the trichoscope; 2. Those who have received other treatments in the past 3 months; 3. Those who are allergic to polyglutamic acid repair solution or minoxidil; 4. Those who have been taking oral antiplatelet drugs for a long time or are undergoing anticoagulation-related therapy;

Design outcomes

Primary

MeasureTime frame
The patient's hair density;

Secondary

MeasureTime frame
Subjective visual score;Satisfaction;Scalp symptom score;Quality of life score;

Countries

China

Contacts

Public ContactTang Lulu

The Second Affiliated Hospital of Guangxi Medical University

tanglulu1@yeah.net+86 771 3394217

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026